Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2026)

Bristol Myers Squibb (BMY) has 8 years of Amortization - Intangibles data on file, last reported at $437.0 million in Q1 2026.

• Quarterly Amortization - Intangibles fell 47.35% year-over-year to $437.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 60.19% YoY) and the FY2025 annual result came in at $3.3 billion, down 62.61% from the prior year.
• Amortization - Intangibles declined to $437.0 million in Q1 2026 per BMY's latest filing, from $826.0 million in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $2.4 billion in Q3 2022 and bottomed at $437.0 million in Q1 2026.
• The 5-year median for Amortization - Intangibles is $2.3 billion (2023), against an average of $1.8 billion.
• The widest annual swing landed in 2024, when Amortization - Intangibles grew 7.04%; it then plunged 65.65% in 2025.
• Tracing BMY's Amortization - Intangibles over 5 years: stood at $2.3 billion in 2022, then decreased by 2.77% to $2.3 billion in 2023, then retreated by 25.68% to $1.7 billion in 2024, then slumped by 51.21% to $826.0 million in 2025, then slumped by 47.09% to $437.0 million in 2026.
• Per Business Quant, the three latest BMY Amortization - Intangibles figures stand at $437.0 million (Q1 2026), $826.0 million (Q4 2025), and $831.0 million (Q3 2025).

Peer Comparison